[{"id":"f4fba051-456f-43bd-8347-e3da4fc0a554","acronym":"","url":"https://clinicaltrials.gov/study/NCT03042182","created_at":"2021-01-18T14:58:42.306Z","updated_at":"2024-07-02T16:36:56.081Z","phase":"Phase 1/2","brief_title":"Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma","source_id_and_acronym":"NCT03042182","lead_sponsor":"Immunitor LLC","biomarkers":" CA 19-9","pipe":"","alterations":" ","tags":["CA 19-9"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e oral therapeutic vaccine V3-X"],"overall_status":"Unknown status","enrollment":" Enrollment 20","initiation":"Initiation: 02/20/2017","start_date":" 02/20/2017","primary_txt":" Primary completion: 02/20/2020","primary_completion_date":" 02/20/2020","study_txt":" Completion: 04/20/2020","study_completion_date":" 04/20/2020","last_update_posted":"2019-08-30"}]